Sept 26 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. ANNOUNCES MANAGEMENT CHANGES.
* QUALIGEN THERAPEUTICS INC - APPOINTED CAMPBELL BECHER AS
PRESIDENT
* QUALIGEN THERAPEUTICS INC - CHRISTOPHER LOTZ, CHIEF
FINANCIAL
OFFICE ALSO TENDERED HIS RESIGNATION FROM COMPANY
* QUALIGEN THERAPEUTICS INC - APPOINTED KEVIN RICHARDSON AS
INTERIM CEO AND CFO AS WELL AS A MEMBER OF BOARD
* QUALIGEN THERAPEUTICS INC: MICHAEL POIRIERTO RESIGN AS
CHIEF
EXECUTIVE OFFICER AND CHAIRMAN OF BOARD OF COMPANY, EFFECTIVE
IMMEDIATELY
Source text for Eikon: ID:nGNX5kYQMN
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))